These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35831256)

  • 1. Gastrointestinal tract involvement of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after cord blood transplantation.
    Wakamatsu H; Akahane K; Kasai S; Watanabe A; Goi K
    Pediatr Int; 2022 Jan; 64(1):e15233. PubMed ID: 35831256
    [No Abstract]   [Full Text] [Related]  

  • 2. Epstein-Barr virus post-transplant lymphoproliferative disease (PTLD) after hematopoietic stem cell transplantation.
    Ru Y; Chen J; Wu D
    Eur J Haematol; 2018 Sep; 101(3):283-290. PubMed ID: 29949208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines.
    Styczynski J; van der Velden W; Fox CP; Engelhard D; de la Camara R; Cordonnier C; Ljungman P;
    Haematologica; 2016 Jul; 101(7):803-11. PubMed ID: 27365460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus and Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation.
    Tsao SY; Chang KC; Chen YP; Yeh YM; Su WC; Chen TY
    Ann Hematol; 2011 Jan; 90(1):113-4. PubMed ID: 20369358
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk.
    Van Besien K; Bachier-Rodriguez L; Satlin M; Brown MA; Gergis U; Guarneri D; Hsu J; Phillips AA; Mayer SA; Singh AD; Soave R; Rossi A; Small CB; Walsh TJ; Rennert H; Shore TB
    Leuk Lymphoma; 2019 Jul; 60(7):1693-1696. PubMed ID: 30741059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chinese consensus on the diagnosis and management of Epstein-Barr virus-related post-transplant lymphoproliferative disorders after hematopoietic stem cell transplantation (2022)].
    ;
    Zhonghua Xue Ye Xue Za Zhi; 2022 Sep; 43(9):716-725. PubMed ID: 36709164
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gastrointestinal post-transplant lymphoproliferative disorder with rapidly forming characteristic lesions after cord blood transplantation: a report of two cases].
    Sato Y; Sumi M; Ueki T; Kaiume H; Kirihara T; Takeda W; Kurihara T; Sato K; Hiroshima Y; Tokutake K; Kimura T; Watanabe M; Kobayashi H
    Rinsho Ketsueki; 2016; 57(12):2496-2501. PubMed ID: 28090016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of Rituximab-resistant Epstein-Barr virus-associated post-transplant lymphoproliferative disorder using R-CHOP.
    Kuriyama T; Kawano N; Yamashita K; Ueda A
    J Clin Exp Hematop; 2014; 54(2):149-53. PubMed ID: 25318948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orbital Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a 13-year-old girl with cord blood transplantation.
    Shigemura T; Maruyama Y; Shigeto S; Nakazawa Y; Kanno H
    Transpl Infect Dis; 2021 Jun; 23(3):e13536. PubMed ID: 33264446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
    Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K
    Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV+ posttransplant lymphoproliferative disease of the retina presenting as cytomegalovirus retinitis.
    Wong IY; Ho WL; Iu LP; Lau KHP; Ho PL; Kwong YL
    Ann Hematol; 2021 Dec; 100(12):3061-3063. PubMed ID: 33009936
    [No Abstract]   [Full Text] [Related]  

  • 12. First report of Epstein-Barr virus lymphoproliferative disease after cord blood transplantation.
    Sirvent N; Reviron D; de Lamballerie X; Michel G
    Bone Marrow Transplant; 2000 Jan; 25(1):120-1. PubMed ID: 10654028
    [No Abstract]   [Full Text] [Related]  

  • 13. Epstein-barr virus DNAemia monitoring for the management of post-transplant lymphoproliferative disorder.
    Kalra A; Roessner C; Jupp J; Williamson T; Tellier R; Chaudhry A; Khan F; Taparia M; Jimenez-Zepeda VH; Stewart DA; Daly A; Storek J
    Cytotherapy; 2018 May; 20(5):706-714. PubMed ID: 29580864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation.
    Zallio F; Primon V; Tamiazzo S; Pini M; Baraldi A; Corsetti MT; Gotta F; Bertassello C; Salvi F; Rocchetti A; Levis A
    Clin Transplant; 2013; 27(4):E491-7. PubMed ID: 23781897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Allen UD; Preiksaitis JK;
    Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-associated posttransplant lymphoproliferative disorder after a cord blood stem cell transplantation presenting with pulmonary nodules.
    Shimasaki N; Mori T; Shimada H; Sugita M; Higuchi M; Mukai M; Morio T; Okamoto S
    J Pediatr Hematol Oncol; 2004 Feb; 26(2):124-7. PubMed ID: 14767205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus related post-transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantation.
    Lindsay J; Yong MK; Greenwood M; Kong DCM; Chen SCA; Rawlinson W; Slavin M
    Rev Med Virol; 2020 Jul; 30(4):e2108. PubMed ID: 32301566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.
    Uhlin M; Wikell H; Sundin M; Blennow O; Maeurer M; Ringden O; Winiarski J; Ljungman P; Remberger M; Mattsson J
    Haematologica; 2014 Feb; 99(2):346-52. PubMed ID: 24056821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-associated leukemic lymphoma after allogeneic stem cell transplantation.
    Takamatsu H; Araki R; Nishimura R; Yachie A; Espinoza JL; Okumura H; Yoshida T; Kuzushima K; Nakao S
    J Clin Virol; 2016 Jul; 80():82-6. PubMed ID: 27218416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manifestations of fulminant CD8 T-cell post-transplant lymphoproliferative disorder following the administration of rituximab for lymphadenopathy with a high level of Epstein-Barr Virus (EBV) replication after allogeneic hematopoietic stem cell transplantation.
    Tanaka T; Takizawa J; Miyakoshi S; Kozakai T; Fuse K; Shibasaki Y; Moriyama M; Ohshima K; Toba K; Furukawa T; Sone H; Masuko M
    Intern Med; 2014; 53(18):2115-9. PubMed ID: 25224199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.